Provided by Tiger Trade Technology Pte. Ltd.

Conduit Pharmaceuticals Inc.

0.0088
-0.0001-1.12%
Volume:2.00K
Turnover:17.70
Market Cap:- -
PE:0.00
High:0.0089
Open:0.0089
Low:0.0088
Close:0.0089
52wk High:0.0217
52wk Low:0.0050
Shares:- -
Float Shares:- -
Volume Ratio:0.22
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-473.6643
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Conduit Pharmaceuticals Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.